The Conventus DRS Implant is pending 510(k) FDA approval.
More Articles on Orthopedic Devices:
Spinal Elements Launches Ti-Bond
Exactech Announces 2Q Revenue of $55.2M, Up 7%
DJO Global 2Q Net Sales Reach $286M, a 2.9% Increasea
Conventus Orthopaedics Completes Enrollment for Fracture Implant Trial
Written by Jaimie Oh | August 02, 2012
Conventus Orthopaedics has completed enrollment of an international multi-center clinical study of the Conventus DRS Implant with 60 patients from six institutions throughout Germany and Switzerland.
The Conventus DRS Implant is designed to provide a less invasive means for orthopedic surgeons to treat patients with distal radius fractures. The surgical procedure requires only a two to three centimeter incision on the forearm and a few small incisions distally. The technique is shown to reduce surgical trauma by as much as 70 percent compared to traditional plate and screws fixation and preserve soft tissues around the fracture to minimize stiffness, swelling and pain.
The Conventus DRS Implant is pending 510(k) FDA approval.
The Conventus DRS Implant is pending 510(k) FDA approval.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.